SNCA and Parkinson disease: Combined with our current research results, PEMFs might primarily exert a protective influence on in vitro models of PD induced by MPP+ through multiple mechanisms, thereby expanding opportunities to develop therapeutics to prevent dopaminergic neuron death and promote the degradation of α-synuclein.